ASRS
IOVA icon

Arizona State Retirement System’s Iovance Biotherapeutics IOVA Stock Holding History

Arizona State Retirement System’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$402K Buy
96,622
+12,138
+14% +$46.1K ﹤0.01% 1636
2026
Q1 		$297K Sell
84,484
-1,006
-1% -$3.22K ﹤0.01% 1728
2025
Q4 		$233K Buy
85,490
+6,640
+8% +$15.4K ﹤0.01% 1859
2025
Q3 		$171K Buy
78,850
+2,717
+4% +$6.42K ﹤0.01% 1995
2025
Q2 		$131K Buy
76,133
+14,861
+24% +$37K ﹤0.01% 1993
2025
Q1 		$204K Sell
61,272
-386
-0.6% -$1.99K ﹤0.01% 1878
2024
Q4 		$456K Buy
61,658
+5,255
+9% +$48.7K ﹤0.01% 1526
2024
Q3 		$530K Buy
56,403
+1,669
+3% +$15.8K ﹤0.01% 1451
2024
Q2 		$439K Buy
54,734
+1,985
+4% +$21.3K ﹤0.01% 1504
2024
Q1 		$782K Sell
52,749
-9,589
-15% -$112K 0.01% 1184
2023
Q4 		$507K Sell
62,338
-1,050
-2% -$5.49K ﹤0.01% 1434
2023
Q3 		$288K Buy
63,388
+10,282
+19% +$67.1K ﹤0.01% 1690
2023
Q2 		$374K Buy
53,106
+18,805
+55% +$135K ﹤0.01% 1583
2023
Q1 		$210K Buy
34,301
+906
+3% +$6.25K ﹤0.01% 1913
2022
Q4 		$213K Buy
33,395
+1,362
+4% +$10.6K ﹤0.01% 1874
2022
Q3 		$307K Buy
32,033
+88
+0.3% +$1.01K ﹤0.01% 1619
2022
Q2 		$353K Sell
31,945
-1,985
-6% -$26K ﹤0.01% 1572
2022
Q1 		$565K Buy
33,930
+549
+2% +$8.49K ﹤0.01% 1389
2021
Q4 		$637K Buy
33,381
+73
+0.2% +$1.61K ﹤0.01% 1388
2021
Q3 		$821K Buy
33,308
+1,346
+4% +$31.7K 0.01% 1219
2021
Q2 		$832K Sell
31,962
-64
-0.2% -$1.66K 0.01% 1232
2021
Q1 		$1.01M Buy
32,026
+174
+0.5% +$7.21K 0.01% 1101
2020
Q4 		$1.48M Sell
31,852
-607
-2% -$24.1K 0.01% 825
2020
Q3 		$1.07M Buy
32,459
+8,218
+34% +$252K 0.01% 882
2020
Q2 		$665K Sell
24,241
-941
-4% -$30.9K 0.01% 971
2020
Q1 		$754K Buy
+25,182
New +$668K 0.01% 791

Other funds holding IOVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Arizona State Retirement System's IOVA Position: Q2 2026 in Review

Arizona State Retirement System increased its Iovance Biotherapeutics (IOVA) stake by 14% in Q2 2026, buying an estimated $46.1K and bringing the position to 96,622 shares worth $402K. The position accounts for ﹤0.01% of the portfolio, ranked #1636.

Arizona State Retirement System first reported a position in IOVA in Q1 2020 and has held it in 26 quarters since. The position peaked at $1.48M in Q4 2020. 292 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.

  • Arizona State Retirement System held 96,622 shares of Iovance Biotherapeutics worth $402K as of Q2 2026.
  • Arizona State Retirement System bought 12,138 Iovance Biotherapeutics shares in Q2 2026, an estimated $46.1K.
  • Iovance Biotherapeutics made up ﹤0.01% of Arizona State Retirement System's portfolio in Q2 2026, its #1636 holding.
  • Arizona State Retirement System first reported a position in Iovance Biotherapeutics in Q1 2020 and has held it in 26 quarters since.
  • Arizona State Retirement System's Iovance Biotherapeutics position peaked at $1.48M in Q4 2020.
  • 292 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.

Based on Arizona State Retirement System's 13F filing for Q2 2026, filed 7 Aug 2026.